Verrica Pharmaceuticals
VRCA
#9174
Rank
โ‚ฌ93.41 M
Marketcap
5,84ย โ‚ฌ
Share price
4.54%
Change (1 day)
-9.13%
Change (1 year)

Earnings for Verrica Pharmaceuticals (VRCA)

Earnings in 2025 (TTM): -โ‚ฌ16.75 Million

According to Verrica Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ30.82 Million. In 2024 the company made an earning of -โ‚ฌ56.79 Million a decrease over its 2023 earnings that were of -โ‚ฌ53.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verrica Pharmaceuticals from 2017 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ16.75 Million-70.51%
2024 -โ‚ฌ56.79 Million6.56%
2023 -โ‚ฌ53.3 Million183.19%
2022 -โ‚ฌ18.82 Million-27.7%
2021 -โ‚ฌ26.03 Million-22.38%
2020 -โ‚ฌ33.54 Million38.87%
2019 -โ‚ฌ24.15 Million44.49%
2018 -โ‚ฌ16.72 Million343.48%
2017 -โ‚ฌ3.77 Million